Chondroitin sulphate given orally was found to be effective in reducing pain, improving function, and reducing NSAID and analgesic consumption in seven randomised double-blind trials involving 702 patients with osteoarthritis of hip or knee over three months or more.
Searching of several electronic databases was for randomised, double-blind studies of chondroitin sulphate in osteoarthritis of hip or knee. Outcomes of interest were: Lequesne index, patient or physician global evaluation, pain, or walking time, or NSAID or analgesic drug use. Baseline characteristics had to show that patient characteristics were homogeneous.
Chondroitin sulphate for osteoarthritis
Linear Mode
